Norges Bank’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,621
Closed -$225K 1128
2025
Q4
$225K Buy
+7,621
New +$212K ﹤0.01% 1565
2025
Q1
Sell
-52,621
Closed -$1.33M 1835
2024
Q4
$1.33M Sell
52,621
-261,000
-83% -$6.61M ﹤0.01% 1727
2024
Q3
$7.82M Sell
313,621
-467,000
-60% -$13.8M ﹤0.01% 1419
2024
Q2
$23.1M Sell
780,621
-405,000
-34% -$11.2M ﹤0.01% 1181
2024
Q1
$35.7M Sell
1,185,621
-1,524,865
-56% -$42.3M 0.01% 1080
2023
Q4
$77.5M Buy
2,710,486
+5,000
+0.2% +$147K 0.01% 709
2023
Q3
$100M Hold
2,705,486
0.02% 558
2023
Q2
$106M Hold
2,705,486
0.02% 559
2023
Q1
$98.8M Buy
2,705,486
+68,296
+3% +$2.16M 0.02% 553
2022
Q4
$81.3M Buy
+2,637,190
New +$81.9M 0.02% 612

Other funds holding RTO

Norges Bank's RTO Position: Q1 2026 in Review

Norges Bank sold out of Rentokil (RTO) in Q1 2026, closing a stake of 7,621 shares — an estimated $225K sold.

Norges Bank first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $106M in Q2 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Norges Bank reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 7,621 Rentokil shares in Q1 2026, an estimated $225K.
  • Norges Bank first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • Norges Bank's Rentokil position peaked at $106M in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.